Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: EyeDrMike who wrote (17828)	1/16/1999 3:55:00 PM
From: Mkilloran	Read Replies (1) \| Respond to of 23519

EyeDrMike....next beer is on you...here's the highlights from the report DRW was expecting $12 mill in international sales and a total of $15.6 mill income in the 4th qtr with a target of (-0.03) EPS. They feel that the international sales did not reach their goal but may come in around $8.5 mill. Domestic sales were stable and no partner agreement was signed before Dec 31st. However due to cost cutting they think Vivus will do a little better then their EPS est of (-0.03). They have a rating of netural-agressive. All this can change with the signing of a Partner and expansion overseas in 1999.